Product NDC: | 0641-2569 |
Proprietary Name: | Dipyridamole |
Non Proprietary Name: | Dipyridamole |
Active Ingredient(s): | 5 mg/mL & nbsp; Dipyridamole |
Administration Route(s): | INTRAVENOUS |
Dosage Form(s): | INJECTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0641-2569 |
Labeler Name: | West-ward Pharmaceutical Corp. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA074521 |
Marketing Category: | ANDA |
Start Marketing Date: | 19961018 |
Package NDC: | 0641-2569-44 |
Package Description: | 5 VIAL in 1 CARTON (0641-2569-44) > 10 mL in 1 VIAL (0641-2569-41) |
NDC Code | 0641-2569-44 |
Proprietary Name | Dipyridamole |
Package Description | 5 VIAL in 1 CARTON (0641-2569-44) > 10 mL in 1 VIAL (0641-2569-41) |
Product NDC | 0641-2569 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Dipyridamole |
Dosage Form Name | INJECTION |
Route Name | INTRAVENOUS |
Start Marketing Date | 19961018 |
Marketing Category Name | ANDA |
Labeler Name | West-ward Pharmaceutical Corp. |
Substance Name | DIPYRIDAMOLE |
Strength Number | 5 |
Strength Unit | mg/mL |
Pharmaceutical Classes | Decreased Platelet Aggregation [PE],Platelet Aggregation Inhibitor [EPC] |